Towards personalizing haemophilia care: Using the Haemophilia Severity Score to assess 178 patients in a single institution

Haemophilia

Volumn 20, Issue 1, 2014, Pages 9-14

  Vyas, S ^a   Enockson, C ^a   Hernandez, L ^a   Valentino, L A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bleeding; Factor; Haemophilia; Phenotype; Variability

Indexed keywords

ARTICLE; CHILD; FEMALE; HEMARTHROSIS; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEMOPHILIA SEVERITY SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT CARE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

BLEEDING; FACTOR; HAEMOPHILIA; PHENOTYPE; VARIABILITY;

ADOLESCENT; BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HUMANS; INDIVIDUALIZED MEDICINE; INFANT; MALE; PHENOTYPE; SEVERITY OF ILLNESS INDEX;

EID: 84890860261     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12227     Document Type: Article

References (11)

1. Aledort LM, Haschmeyer RH, Pettersson H; the Orthopaedic Outcome Study Group. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. J Intern Med 1994; 236: 391-9.
2. Grünewald M, Siegemund A, Grünewald A, Konegan A, Koksch M, Griesshammer M. Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia. Haemophilia 2002; 8: 768-75.
3. Santagostino E, Mancuso ME, Tripodi A et al. Severe haemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile. J Thromb Haemost 2010; 8: 737-43.
4. Van Dijk K, Fischer K, Van Der Bom JG, Grobbee E, Van Den Berg HM. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed. Haemophilia 2005; 11: 438-43.
5. Van dDijk K, Van Der Bom JG, Fischer K, De Groot PG, Van Den Berg HM. Phenotype of severe haemophilia A and plasma levels of risk factors for thrombosis. J Thromb Haemost 2007; 5: 1062-4.
6. Nichols WC, Amano K, Cacheris PM et al. Moderation of haemophilia A phenotype by the factor V R506Q mutation. Blood 1996; 88: 1183-7.
7. Schulman E, Elde A, Holmstrom M, Stahlber G, Odeberg J, Blomback M. Validation of a composite score for clinical severity of haemophilia. J Thromb Haemost 2008; 6: 1113-21.
8. Fischer K, Van Der Bom JG, Mauser-Bunschoten EP et al. Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy. Haemophilia 2001; 7: 446-52.
9. Löfqvist T, Nilsson IM, Berntorp E, Petterson H. Haemophilia prophylaxis in young patients: a long-term follow-up. J Intern Med 1997; 241: 395-400.
10. Schulman S, Eelde A. Confusion around the official classification of arthropathy. Haemophilia 2007; 13: 117-9.
11. Pai KM, Walker I, Almonte T, Chan AK, Sek J, Decker K. Comparing bleed frequency and factor concentrate use between haemophilia A and haemophilia B. J Thromb Haemost 2005; 3(Suppl. 1): Abstr P0807.